LAG3's Enigmatic Mechanism of Action

Front Immunol. 2021 Jan 8:11:615317. doi: 10.3389/fimmu.2020.615317. eCollection 2020.

Abstract

LAG3 is an important immune checkpoint with relevance in cancer, infectious disease and autoimmunity. However, despite LAG3's role in immune exhaustion and the great potential of LAG3 inhibition as treatment, much remains unknown about its biology, particularly its mechanism of action. This review describes the knowns, unknowns and controversies surrounding LAG3. This includes examination of how LAG3 is regulated transcriptionally and post-translationally by endocytosis and proteolytic cleavage. We also discuss the interactions of LAG3 with its ligands and the purpose thereof. Finally, we review LAG3's mechanism of action, including the roles of LAG3 intracellular motifs and the lack of a role for CD4 competition. Overall, understanding the biology of LAG3 can provide greater insight on LAG3 function, which may broaden the appreciation for LAG3's role in disease and potentially aid in the development of targeted therapies.

Keywords: LAG3; Lymphocyte activation gene-3; checkpoint inhibition; immune checkpoint; immune checkpoint inhibitors; immune exhaustion; mechanism of action.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • ADAM10 Protein / metabolism
  • ADAM17 Protein / metabolism
  • Amino Acid Motifs
  • Antigens, CD / chemistry
  • Antigens, CD / physiology*
  • Clinical Trials as Topic
  • Dendritic Cells / metabolism
  • Endocytosis
  • Gene Expression Regulation
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use
  • Immune Checkpoint Proteins / chemistry
  • Immune Checkpoint Proteins / physiology*
  • Ligands
  • Lymphocyte Activation Gene 3 Protein
  • Lymphocyte Subsets / metabolism
  • Molecular Targeted Therapy
  • Neoplasms / drug therapy
  • Neoplasms / immunology
  • Neurons / metabolism
  • Protein Biosynthesis
  • Protein Processing, Post-Translational
  • Receptors, Antigen, T-Cell / physiology
  • Transcription, Genetic

Substances

  • Antigens, CD
  • Immune Checkpoint Inhibitors
  • Immune Checkpoint Proteins
  • Ligands
  • Receptors, Antigen, T-Cell
  • ADAM10 Protein
  • ADAM17 Protein
  • Lymphocyte Activation Gene 3 Protein
  • Lag3 protein, human

Grants and funding